Clinical Trial

Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

Recruiting
View on ClinicalTrials.gov →
Summary
This is a cross-sectional study that will be conducted across Japan using an online patient-reported outcome questionnaire. This study tries to find out the attitudes toward and experiences of the emotional and/or social impact of side effects associated with antifibrotic (AF) treatment among Japanese patients with Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF), and how are these attitudes associated with patients' individual characteristics.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-13
Trial Details
NCT Number NCT07743996
Lead Sponsor Boehringer Ingelheim
Conditions Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Enrollment 100 participants
Start Date 2026-08-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-12